Download Our DHN Survey Result 2024
Exclusive
Realize your Healthcare’s Digital Transformation journey with ScaleHealthTech Learn More

DeepTek.ai's CXR Analyser Gains FDA Approval for Chest X-ray AI Solution

Written by : Aishwarya Sarthe

October 17, 2023

Category Img

The advanced technology utilises deep learning algorithms to detect anomalies in chest X-rays, offering automated analysis and precise identification of suspicious areas to aid clinicians in accurate interpretations.

Pune-based DeepTek.ai, an AI-radiology company, has received US Food and Drug Administration (FDA) clearance for its Chest X-ray AI solution, the CXR Analyser. 

The advanced technology utilises deep learning algorithms to detect anomalies in chest X-rays, offering automated analysis and precise identification of suspicious areas to aid clinicians in accurate interpretations.

Commenting on the same, Dr Amit Kharat, cofounder, DeepTek.ai, stated, "DeepTek CXR Analyser v1.0 is a game-changer, reducing radiologist workload by an impressive 30'“50 percent. With FDA clearance, we're accessing the vast US healthcare market and impacting lives globally."

The CXR Analyser comprehensively covers the chest area, providing analysis for a wide spectrum of lung, pleural, and cardiac pathologies and foreign bodies/hardware. It's compatible with various X-ray machines, from hospital-based to ultra-portable units, showcasing its versatility and effectiveness.

By detecting and locating suspicious lesions in chest X-rays, this AI model expedites decision-making crucial for diagnosing conditions such as lung infections, cancer, and chronic lung diseases. 

Given the extensive usage of chest X-rays, with 1.5 billion conducted annually out of 3.5 billion total X-rays, precise interpretation becomes imperative. The shortage of radiologists further underscores the role of AI in addressing this challenge.

Established in 2017, DeepTek.ai uses AI technology to develop an advanced decision support system tailored for radiologists. The company's solutions are designed to alleviate radiologists' workload and expedite diagnosis. 

In a significant development in June, DeepTek.ai secured  India's first US-FDA clearance for their AI-powered Augmento platform, further solidifying its commitment to transforming radiology through artificial intelligence.

Similarly, in September, Qure.ai achieved FDA clearance for its AI-powered chest X-ray solution, qXR-CTR. This advanced technology employs a deep-learning-based computer vision algorithm designed to automate the assessment of cardiothoracic ratio (CTR) on chest radiographs, enhancing efficiency and accuracy for physicians across various healthcare settings.


About Chime India

The College of Healthcare Information Management Executives (CHIME) is an executive organization dedicated to serving senior digital health leaders. CHIME includes more than 5,000 members in 56 countries and two US territories and partners with over 150 healthcare IT businesses and professional services firms. CHIME enables its members and business partners to collaborate, exchange ideas, develop professionally and advocate the effective use of information management to improve the health and care throughout the communities they serve. CHIME's members are chief information officers (CIOs), chief medical information officers (CMIOs), chief nursing information officers (CNIOs), chief innovation officers (CIOs), chief digital officers (CDOs), and other senior healthcare leaders. The CHIME India Chapter became the first international chapter outside North America in 2016 and is now a community of over 70+ members in India. For more information, please visit www.chimecentral.org

ABOUT US

Digital Health News ( DHN) is India’s first dedicated digital health news platform launched by Industry recognized HealthTech Leaders. DHN Is Industry’s Leading Source Of HealthTech Business, Insights, Trends And Policy News.

DHN Provides In-Depth Data Analysis And Covers Most Impactful News As They Happen Across Entire Ecosystem Including Emerging Technology Trends And Innovations, Digital Health Startups, Hospitals, Health Insurance, Govt. Agencies & Policies, Pharmaceuticals And Biotech.

CONTACT US

© Digital Health News 2024